Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01305291 · ClinicalTrials.gov registry record · NA
Fibersol-2 Clinical Trials Related to Appetite
A NA study, sponsored by Iowa State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01305291 is a NA study that has completed, run by Iowa State University. The registered enrollment target is 20 participants.
The verdict
NCT01305291, a NA study, has completed, sponsored by Iowa State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Emerging research suggests fiber, particularly digestion-resistant maltodextrins such as Fibersol-2, may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut. This research aims to determine whether or not Fibersol-2 may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT digestion-resistant maltodextrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01305291
The ClinicalTrials.gov registry entry for NCT01305291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iowa State University, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01305291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01305291 about?
NCT01305291 is a clinical study titled "Fibersol-2 Clinical Trials Related to Appetite". Emerging research suggests fiber, particularly digestion-resistant maltodextrins such as Fibersol-2, may impact satiety, by decreasing hunger, prolonging satiation, and/or increasing satiety signals from the gut. This research aims to determine whether or not Fibersol-2 may impact satiety, by decrea...
What is the current status of trial NCT01305291?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT01305291?
The interventions under investigation include: placebo (OTHER), digestion-resistant maltodextrin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01305291?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.